Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q3 2013 (← Previous) (Next →)

Filing Date: Nov 20, 2013

Total Value: $954M (100.0% shares, 0.0% debt)

Holdings (34)

— ViroPharma Incorporated 12.7%
Value $121M Shares 3,093,291 Share Price $39.26 Est. Cost/Share $28.65 Unrealized @ Report Date —
— Cyberonics, Inc. 10.2%
Value $97.4M Shares 1,919,518 Share Price $50.74 Est. Cost/Share $51.92 Unrealized @ Report Date —
UTHR United Therapeutics Corp 8.8%
Value $83.85M Shares 1,063,442 Share Price $78.85 * Est. Cost/Share $65.75 Unrealized @ Report Date +11.2%
— Auxilium Pharmaceuticals, Inc. 8.7%
Value $83.06M Shares 4,563,520 Share Price $18.20 Est. Cost/Share $17.22 Unrealized @ Report Date —
— Cubist Pharmaceuticals, Inc. 6.8%
Value $64.48M Shares 1,014,611 Share Price $63.55 Est. Cost/Share $52.17 Unrealized @ Report Date —
— Intermune Inc. 5.8%
Value $55.3M Shares 3,595,756 Share Price $15.38 Est. Cost/Share $12.54 Unrealized @ Report Date —
— Abiomed Inc. 5.3%
Value $50.59M Shares 2,654,347 Share Price $19.06 Est. Cost/Share $21.24 Unrealized @ Report Date —
STAA STAAR Surgical Company 4.6%
Value $43.48M Shares 3,211,318 Share Price $13.54 * Est. Cost/Share $8.10 Unrealized @ Report Date +45.2%
— Onyx Pharmaceuticals, Inc. 4.5%
Value $42.83M Shares 343,473 Share Price $124.70 Est. Cost/Share $86.82 Unrealized @ Report Date —
BMRN Biomarin Pharmaceuticals, Inc 4.3%
Value $40.73M Shares 564,287 Share Price $72.17 * Est. Cost/Share $62.32 Unrealized @ Report Date +6.6%
— Questcor Pharmaceuticals, Inc. 4.0%
Value $38.05M Shares 655,997 Share Price $58.00 Est. Cost/Share $45.44 Unrealized @ Report Date —
— AMAG Pharmaceuticals, Inc. 3.9%
Value $36.84M Shares 1,715,377 Share Price $21.47 Est. Cost/Share $22.23 Unrealized @ Report Date —
VNDA Vanda Pharmaceutical Inc. 3.3%
Value $31.85M Shares 2,908,314 Share Price $10.95 * Est. Cost/Share $7.45 Unrealized @ Report Date +43.4%
— Rigel Pharmaceuticals Inc. 2.4%
Value $22.55M Shares 6,299,664 Share Price $3.58 Est. Cost/Share $3.43 Unrealized @ Report Date —
— Sequenom Inc. 2.3%
Value $21.9M Shares 8,202,254 Share Price $2.67 Est. Cost/Share $4.21 Unrealized @ Report Date —
— Anacor Pharmaceuticals, Inc. 1.8%
Value $16.99M Shares 1,600,178 Share Price $10.62 Est. Cost/Share $5.59 Unrealized @ Report Date —
— Momenta Pharmaceuticals, Inc. 1.7%
Value $16.36M Shares 1,136,676 Share Price $14.39 Est. Cost/Share $15.06 Unrealized @ Report Date —
— Kythera BioPharm 1.5%
Value $14.55M Shares 319,113 Share Price $45.59 Est. Cost/Share $40.58 Unrealized @ Report Date —
— Alimera Sciences, Inc. 1.4%
Value $13.67M Shares 3,634,984 Share Price $3.76 Est. Cost/Share $4.88 Unrealized @ Report Date —
FOLD Amicus Therapeutics, Inc. 1.1%
Value $10.72M Shares 4,622,230 Share Price $2.32 * Est. Cost/Share $3.07 Unrealized @ Report Date -18.4%
— QLT Inc. 1.0%
Value $9.503M Shares 2,052,411 Share Price $4.63 Est. Cost/Share $4.40 Unrealized @ Report Date —
EXAS Exact Sciences Corp 1.0%
Value $9.203M Shares 779,876 Share Price $11.80 * Est. Cost/Share $12.83 Unrealized @ Report Date 0.0%
— AVEO Pharmaceuticals, Inc. 0.8%
Value $7.229M Shares 3,509,205 Share Price $2.06 Est. Cost/Share $2.50 Unrealized @ Report Date —
— Savient Pharmaceuticals, Inc. 0.6%
Value $5.465M Shares 8,752,981 Share Price $0.62 Est. Cost/Share $0.56 Unrealized @ Report Date —
INSM Insmed, Inc. 0.4%
Value $4.157M Shares 266,299 Share Price $15.61 * Est. Cost/Share $10.22 Unrealized @ Report Date +24.3%
— Spectrum Pharmaceuticals Inc. 0.3%
Value $3.318M Shares 395,985 Share Price $8.38 Est. Cost/Share $7.46 Unrealized @ Report Date —
— Cytokinetics Inc. 0.2%
Value $1.98M Shares 261,544 Share Price $7.57 Est. Cost/Share $11.57 Unrealized @ Report Date —
— Xoma Ltd. 0.2%
Value $1.878M Shares 418,183 Share Price $4.49 Est. Cost/Share $3.63 Unrealized @ Report Date —
PRTA Prothena Corp PLC 0.2%
Value $1.79M Shares 88,500 Share Price $20.23 * Est. Cost/Share $9.30 Unrealized @ Report Date +90.2%
— Hyperion Therapeutics 0.2%
Value $1.638M Shares 62,700 Share Price $26.12 Est. Cost/Share $22.00 Unrealized @ Report Date —
— NxStage Medical, Inc. 0.1%
Value $581K Shares 44,129 Share Price $13.17 Est. Cost/Share $14.28 Unrealized @ Report Date —
— Celgene Corp. 0.0%
Value $260K Shares 1,690 Share Price $153.85 Est. Cost/Share $153.85 Unrealized @ Report Date —
— Sophiris Bio Inc 0.0%
Value $257K Shares 55,000 Share Price $4.67 Est. Cost/Share $4.67 Unrealized @ Report Date —
— Align Technology, Inc. 0.0%
Value $245K Shares 5,088 Share Price $48.15 Est. Cost/Share $48.15 Unrealized @ Report Date —